100% Secure Payments
Tender Details
- Country: USA
- Summary: Bupropion HCL ER
- UST Ref No: 126374201
- Deadline: 15 Feb 2022
- Competition: ICB
- Financier: Self Financed
- Purchaser Ownership: Public
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: SPE2D2-21-R-0105
- Purchaser's Detail :
- Description :
- Description
Modification P00008 SPE2D223D0002 is issued to invoke option year 3 for Bupropion HCL ER National Contract.
Modification P00007 SPE2D223D0002 is issued in accordance with DoD Class Deviation 2025-O0003 and Class Deviation 2025-O0004 into subject solicitation.
Modification P00006 SPE2D223D0002 is issued to invoke option year 2 for Bupropion HCL ER National Contract.
Modification P00005 SPE2D223D0002 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation.
BUPROPION HCL ER NATIONAL CONTRACTS SOLICITATION - Documents :
Purchaser : DEPT OF DEFENSE | DEFENSE LOGISTICS AGENCY
MEDICAL SUPPLY CHAIN FSGB 700 ROBBINS AVENUE, PHILADELPHIA , PA 19111, USA
Primary Point of Contact: Kyle Lewicki, kyle.lewicki@dla.mil, Phone Number 4457370977
Secondary Point of Contact: Jason C. Wray, Jason.Wray@dla.mil, Phone Number 44573...
Email :kyle.lewicki@dla.mil
Modification-P00008-SPE2D223D0002-Option-Year-3.PDF
Modification-P00007-SPE2D223D0002.PDF
Modification-P00006-SPE2D223D0002-Option-Year-2.PDF
Modification-P00005-SPE2D223D0002.PDF
Signed-SPE2D223D0002-P00003.pdf
Revised-Schedule-of-Supplies.pdf
Bilaterally-Signed-SPE2D223D0002-P00001.pdf
Bilaterally-Signed-Bupropion-HCL-ER-Award-SPE2D2-2.pdf
REVISED-Page-104-Appendix-B.pdf
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN
